DLBCL Germinal Center B-Cell Type
3 clinical trials · Condition
◉ Watch DLBCL Germinal Center B-Cell Type
| Record | Firm | Date |
|---|---|---|
| Study of SGR-1505 in Mature B-Cell Neoplasms (NCT05544019) | Schrödinger, Inc. | 2023-04-10 |
| Selinexor Plus R-CHOP in High-risk GCB-subtype Diffuse Large B-Cell Lymphoma (NCT05422066) | Li Zhiming | 2022-07-26 |
| Iomab-ACT: A Pilot Study of 131-I Apamistamab Followed by CD19-Targeted CAR T-Cell Therapy for Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia or Diffuse Large B-Cell Lymphoma (NCT04512716) | Memorial Sloan Kettering Cancer Center | 2021-02-02 |
Track DLBCL Germinal Center B-Cell Type automatically
Every clearance here is in the API, with alerts when new ones post.